Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7797]

Disappointment caused by NICE decision against olaparib as treatment for ovarian cancer

Disappointment caused by NICE decision against olaparib as treatment for ovarian cancer

Oral contraceptives have prevented over 200,000 cases of endometrial cancer in the last decade

Oral contraceptives have prevented over 200,000 cases of endometrial cancer in the last decade

Genetic chaos in tumours could help predict chemo response

Genetic chaos in tumours could help predict chemo response

Possible reason for drug resistance in breast tumors

Possible reason for drug resistance in breast tumors

Childhood cancer cells drain immune system's batteries

Childhood cancer cells drain immune system's batteries

FDA approves carfilzomib in combination with lenalidomide and dexamethasone for relapsed multiple myeloma

FDA approves carfilzomib in combination with lenalidomide and dexamethasone for relapsed multiple myeloma

Eribulin to remain available to women in England through the national cancer drugs fund

Eribulin to remain available to women in England through the national cancer drugs fund

EU recommends dabrafenib/trametinib combo for treatment of melanoma

EU recommends dabrafenib/trametinib combo for treatment of melanoma

New ‘chemotherapy booster’ could treat lung and pancreatic cancer

New ‘chemotherapy booster’ could treat lung and pancreatic cancer

FDA approved sonidegib for locally advanced basal cell carcinoma

FDA approved sonidegib for locally advanced basal cell carcinoma

More from ecancer